Truist lowered the firm’s price target on Stryker (SYK) to $392 from $407 and keeps a Hold rating on the shares. The company delivered a small revenue beat with mixed quality earnings upside that was driven by non-op items and tax, which offset a slight operating margin miss, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Stryker Corp’s Earnings Call Highlights Robust Growth
- Stryker’s Mixed Performance and Valuation Concerns Justify Hold Rating with Adjusted Price Target
- Stryker price target lowered to $392 from $407 at Truist
- Stryker’s Strong Q3 Performance and Raised Guidance Justify Buy Rating
- Stryker price target lowered to $405 from $410 at Evercore ISI